Making sense of it: Roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis

Experimental Biology and Medicine

Volumn 232, Issue 1, 2007, Pages 14-26

  Fry, Mark ^a   Hoyda, Ted D ^a   Ferguson, Alastair V ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Adiponectin; Amylin; Area postrema; Cholecystokinin; Circumventricular organs; Energy homeostasis; Ghrelin; Glucose; Leptin; Organum vasculosum of the lamina terminalis; Pancreatic polypeptide; Peptide YY; Satiety signals; Subfornical organ

Indexed keywords

ADIPONECTIN; AMYLIN; CHOLECYSTOKININ; GHRELIN; GLUCOSE; LEPTIN; PANCREAS POLYPEPTIDE; PEPTIDE YY;

AREA POSTREMA; BLOOD BRAIN BARRIER; BRAIN REGION; CENTRAL NERVOUS SYSTEM; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; HOMEOSTASIS; HUMAN; NONHUMAN; NUTRITIONAL STATUS; SATIETY; SENSE ORGAN; SHORT SURVEY; SIGNAL TRANSDUCTION; SUBFORNICAL ORGAN;

AREA POSTREMA; BLOOD-BRAIN BARRIER; BRAIN; EATING; ENERGY METABOLISM; GLUCOSE; HOMEOSTASIS; HORMONES; HUMANS; HYPOTHALAMUS; SUBFORNICAL ORGAN;

EID: 33846123320     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (186)

1. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab 89:2522-2525, 2004.
2. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 299:853-855, 2003.
3. Berthoud HR. Neural control of appetite: cross-talk between homeostatic and non-homeostatic systems. Appetite 43:315-317, 2004.
4. Williams G, Harrold JA, Cutler DJ. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc 59:385-396, 2000.
5. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 104:531-543, 2001.
6. Grill HJ, Kaplan JM. The neuroanatomical axis for control of energy balance. Front Neuroendocrinol 23:2-40, 2002.
7. Hofbauer KG. Molecular pathways to obesity. Int J Obes Relat Metab Disord 26(Suppl 2):S18-S27, 2002.
8. Levin BE. Metabolic sensors: viewing glucosensing neurons from a broader perspective. Physiol Behav 76:397-401, 2002.
9. Saper CB, Chou TC, Elmquist JK. The need to feed: homeostatic and hedonic control of eating. Neuron 36:199-211, 2002.
10. Jobst EE, Enriori PJ, Cowley MA. The electrophysiology of feeding circuits. Trends Endocrinol Metab 15:488-499, 2004.
11. Baura GD, Foster DM, Porte D, Jr, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92:1824-1830, 1993.
12. Banks WA, Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19: 883-889, 1998.
13. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311, 1996.
14. Pan W, Yu Y, Cain CM, Nyberg F, Couraud PO, Kastin AJ. Permeation of growth hormone across the blood-brain barrier. Endocrinology 146:4898-4904, 2005.
15. Wislocki GB, Putnam JT. Note on the anatomy of the areae postremae. Anat Rec 19:281-285, 1920.
16. Wislocki GB, Putnam JT. Further observations on the anatomy and physiology of the areae postremae. Anat Rec 27:151, 1924.
17. Wislocki GB, King LS. The permeability of the hypophysis and hypothalamus to vital dyes, with a study of the hypophyseal vascular supply. Am J Anat 58:421-472, 1936.
18. Wislocki GB, Leduc EH. Vital staining of the hematoencephalic barrier by silver nitrate and trypan blue, with cytological comparisons of the neurohypophysis, pineal body, area postrema, intercolumnal tubercle, and supraoptic crest. J Comp Neurol 96:371-414, 1952.
19. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 7:678-686, 1993.
20. Rodriguez EM, Herrera H, Peruzzo B, Rodriguez S, Hein S, Oksche A. Light- and electron-microscopic immunocytochemistry and lectin histochemistry of the subcommissural organ: evidence for processing of the secretory material. Cell Tissue Res 243:545-559, 1986.
21. Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18:1423-1429, 1997.
22. Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB. Permeability of the blood-brain barrier to amylin. Life Sci 57:1993-2001, 1995.
23. Rethelyi M. Diffusional barrier around the hypothalamic arcuate nucleus in the rat. Brain Res 307:355-358, 1984.
24. Maness LM, Kastin AJ, Farrell CL, Banks WA. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 139:4556-4562, 1998.
25. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484, 2001.
26. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661, 2003.
27. Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822-827, 2002.
28. McKinley MJ, McAllen RM, Davern P, Giles ME, Penschow J, Sunn N, Uschakov A, Oldfield BJ. The sensory circumventricular organs of the mammalian brain. Adv Anat Embryol Cell Biol 172:111-122, 2003.
29. Dellmann HD, Simpson JB. The subfornical organ. Int Rev Cytol 58: 333-421, 1979.
30. Gross PM. Morphology and physiology of capillary systems in subregions of the subfornical organ and area postrema. Can J Physiol Pharmacol 69:1010-1025, 1991.
31. Rhodes CH, Morrell JI, Pfaff DW. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J Comp Neurol 198:45-64, 1981.
32. Miselis RR. The subfornical organ's neural connections and their role in water balance. Peptides 3:501-502, 1982.
33. Miselis RR, Shapiro RE, Hand PJ. Subfornical organ efferents to neural systems for control of body water. Science 205:1022-1025, 1979.
34. Ferguson AV, Day TA, Renaud LP. Subfornical organ stimulation excites paraventricular neurons projecting to dorsal medulla. Am J Physiol 247:R1088-R1092, 1984.
35. Lind RW, Van Hoesen GW, Johnson AK. An HRP study of the connections of the subfornical organ of the rat. J Comp Neurol 210: 265-277, 1982.
36. Weiss ML, Hatton GI. Collateral input to the paraventricular and supraoptic nuclei in rat, I: afferents from the subfornical organ and the anteroventral third ventricle region. Brain Res Bull 24:231-238, 1990.
37. Lind RW. Bi-directional, chemically specified neural connections between the subfornical organ and the midbrain raphe system. Brain Res 384:250-261, 1986.
38. Swanson LW, Lind RW. Neural projections subserving the initiation of a specific motivated behavior in the rat: new projections from the subfornical organ. Brain Res 379:399-403, 1986.
39. Tanaka J, Ushigome A, Hori K, Nomura M. Responses of raphe nucleus projecting subfornical organ neurons to angiotensin II in rats. Brain Res Bull 45:315-318, 1998.
40. Zardetto-Smith AM, Gray TS. A direct neural projection from the nucleus of the solitary tract to the subfornical organ in the rat. Neurosci Lett 80:163-166, 1987.
41. Cottrell GT, Ferguson AV. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept 117:11-23, 2004.
42. McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ. Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol 25(Suppl):S61-S67, 1998.
43. Giles ME, Fernley RT, Nakamura Y, Moeller I, Aldred GP, Ferraro T, Penschow JD, McKinley MJ, Oldfield BJ. Characterization of a specific antibody to the rat angiotensin II AT1 receptor. J Histochem Cytochem 47:507-516, 1999.
44. Armstrong WE, Tian M, Wong H. Electron microscopic analysis of synaptic inputs from the median preoptic nucleus and adjacent regions to the supraoptic nucleus in the rat. J Comp Neurol 373:228-239, 1996.
45. Camacho A, Phillips MI. Horseradish peroxidase study in rat of the neural connections of the organum vasculosum of the lamina terminalis. Neurosci Lett 25:201-204, 1981.
46. Sawchenko PE, Swanson LW. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 218:121-144, 1983.
47. Phillips MI, Camacho A. Neural connections of the organum vasculosum of the lamina terminalis. In: Gross P, Ed. Circumventricular Organs and Body Fluids. Boca Raton: CRC Press, 1987: 157-69.
48. Saper CB, Levisohn D. Afferent connections of the median preoptic nucleus in the rat: anatomical evidence for a cardiovascular integrative mechanism in the anteroventral third ventricular (AV3V) region. Brain Res 288:21-31, 1983.
49. Merchenthaler I, Liposits Z. Mapping of thyrotropin-releasing hormone (TRH) neuronal systems of rat forebrain projecting to the median eminence and the OVLT. Immunocytochemistry combined with retrograde labeling at the light and electron microscopic levels. Acta Biol Hung 45:361-374, 1994.
50. Chernicky CL, Barnes KL, Conomy JP, Ferrario CM. A morphological characterization of the canine area postrema. Neurosci Lett 20: 37-43, 1980.
51. Lanca AJ, van der KD. A serotonin-containing pathway from the area postrema to the parabrachial nucleus in the rat. Neuroscience 14: 1117-1126, 1985.
52. Shapiro RE, Miselis RR. The central neural connections of the area postrema of the rat. J Comp Neurol 234:344-364, 1985.
53. van der KD, Koda LY. Organization of the projections of a circumventricular organ: the area postrema in the rat. J Comp Neurol 20;219:328-338, 1983.
54. Ciriello J, Hrycyshyn AW, Calaresu FR. Glossopharyngeal and vagal afferent projections to the brain stem of the cat: a horseradish peroxidase study. J Auton Nerv Syst 4:63-79, 1981.
55. Davies RO, Kalia M. Carotid sinus nerve projections to the brain stem in the cat. Brain Res Bull 6:531-541, 1981.
56. Kalia M, Mesulam MM. Brain stem projections of sensory and motor components of the vagus complex in the cat: II. Laryngeal, tracheobronchial, pulmonary, cardiac, and gastrointestinal branches. J Comp Neurol 193:467-508, 1980.
57. Larsson LI, Rehfeld JF. Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Evidence for the occurrence of three distinct cell types storing COOH-terminal gastrin immunoreactivity. Histochemistry 58:23-31, 1978.
58. Lilja P, Wiener I, Inoue K, Fried GM, Greeley GH, Jr, Thompson JC. Release of cholecystokinin in response to food and intraduodenal fat in pigs, dogs and man. Surg Gynecol Obstet 159:557-561, 1984.
59. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84:488-495, 1973.
60. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34:154-160, 1981.
61. Fraser PE, Nguyen WK, Surewicz WD, Kirschner DA. Biophys J 60: 1190-1201, 1991.
62. Day HE, McKnight AT, Poat JA, Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33:719-727, 1994.
63. Sayegh AI, Ritter RC. Vagus nerve participates in CCK-induced Fos expression in hindbrain but not myenteric plexus. Brain Res 878:155-162, 2000.
64. Hoffman GE, Smith MS, Verbalis JG. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14:173-213, 1993.
65. Sun K, Ferguson AV. Cholecystokinin activates area postrema neurons in rat brain slices. Am J Physiol 272:R1625-R1630, 1997.
66. Carpenter DO, Briggs DB, Knox AP, Strominger N. Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides. J Neurophysiol 59:358-369, 1988.
67. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84: 8628-8632, 1987.
68. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127:414-417, 1987.
69. Gedulin BR, Rink TJ, Young AA. Dose-response for glucagonostatic effect of amylin in rats. Metabolism 46:67-70, 1997.
70. Silvestre RA, Peiro E, Degano P, Miralles P, Marco J. Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 31:23-31, 1990.
71. Peiro E, Degano P, Silvestre RA, Marco J. Inhibition of insulin release by amylin is not mediated by changes in somatostatin output. Life Sci 49:761-765, 1991.
72. Degano P, Silvestre RA, Salas M, Peiro E, Marco J. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul Pept 43:91-96, 1993.
73. Broderick CL, Brooke GS, DiMarchi RD, Gold G. Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem Biophys Res Commun 177:932-938, 1991.
74. Silvestre RA, Rodriguez-Gallardo J, Gutierrez E, Marco J. Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas. Regul Pept 68:31-35, 1997.
75. Young DA, Deems RO, Deacon RW, McIntosh RH, Foley JE. Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am J Physiol 259:E457-E461, 1990.
76. Lutz TA, Del PE, Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 55: 891-895, 1994.
77. Lutz TA, Del PE, Scharrer E. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16:457-462, 1995.
78. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC. Amylin: a novel action in the brain to reduce body weight. Endocrinology 141: 850-853, 2000.
79. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62:553-567, 1994.
80. Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM. Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol 73:1037-1041, 1995.
81. Paxinos G, Chai SY, Christopoulos G, Huang XF, Toga AW, Wang HQ, Sexton PM. In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain. J Chem Neuroanat 27:217-236, 2004.
82. Barth SW, Riediger T, Lutz TA, Rechkemmer G. Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat. Brain Res 997:97-102, 2004.
83. Riediger T, Schmid HA, Lutz T, Simon E. Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol 281:R1833-R1843, 2001.
84. Riediger T, Schmid HA, Lutz TA, Simon E. Amylin and glucose co-activate area postrema neurons of the rat. Neurosci Lett 328:121-124, 2002.
85. Riediger T, Schmid HA, Young AA, Simon E. Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones. Brain Res 837:161-168, 1999.
86. Riediger T, Rauch M, Schmid HA. Actions of amylin on subfornical organ neurons and on drinking behavior in rats. Am J Physiol 276: R514-R521, 1999.
87. Pulman KJ, Fry WM, Cottrell GT, Ferguson AV. The subfornical organ: a central target for circulating feeding signals. J Neurosci 26: 2022-2030, 2006.
88. Del PE, Schade B, Riediger T, Lutz TA, Scharrer E. Effects of amylin and salmon calcitonin on feeding and drinking behavior in pygmy goats. Physiol Behav 75:593-599, 2002.
89. Bottcher G, Alumets J, Hakanson R, Sundler F. Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man: an electron microscopic study. Regul Pept 13:283-291, 1986.
90. Greeley GH, Jr, Jeng YJ, Gomez G, Hashimoto T, Hill FL, Kern K, Kurosky T, Chuo HF, Thompson JC. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 124:1438-1443, 1989.
91. (1-36). Peptides 10:797-803, 1989.
92. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR, Jr. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51:151-159, 1994.
93. Murphy KG, Bloom SR. Gut hormones in the control of appetite. Exp Physiol 89:507-516, 2004.
94. Track NS, McLeod RS, Mee AV. Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations. Can J Physiol Pharmacol 58:1484-1489, 1980.
95. Grove KL, Chen P, Koegler FH, Schiffmaker A, Susan SM, Cameron JL. Fasting activates neuropeptide Y neurons in the arcuate nucleus and the paraventricular nucleus in the rhesus macaque. Brain Res Mol Brain Res 113:133-138, 2003.
96. Singer LK, Kuper J, Brogan RS, Smith MS, Grove KL. Novel expression of hypothalamic neuropeptide Y during postnatal development in the rat. Neuroreport 11:1075-1080, 2000.
97. Grove KL, Brogan RS, Smith MS. Novel expression of neuropeptide Y (NPY) mRNA in hypothalamic regions during development: region-specific effects of maternal deprivation on NPY and Agouti-related protein mRNA. Endocrinology 142:4771-4776, 2001.
98. Morris BJ. Neuronal localisation of neuropeptide Y gene expression in rat brain. J Comp Neurol 290:358-368, 1989.
99. Gehlert DR, Chronwall BM, Schafer MP, O'Donohue TL. Localization of neuropeptide Y messenger ribonucleic acid in rat and mouse brain by in situ hybridization. Synapse 1:25-31, 1987.
100. Kagotani Y, Hisano S, Tsuruo Y, Daikoku S, Chihara K. Vasopressin-deficient paraventricular magnocellular neurons of homozygous Brattleboro rats synthesize neuropeptide Y. Neurosci Lett 112:37-42, 1990.
101. Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116:477-480, 1982.
102. Balasubramaniam AA. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18:445-457, 1997.
103. Herzog H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480:21-29, 2003.
104. Dumont Y, St-Pierre JA, Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport 7:901-904, 1996.
105. Dumont Y, Fournier A, St-Pierre S, Quirion R. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 22:139-158, 1996.
106. Larsen PJ, Kristensen P. The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex. Brain Res Mol Brain Res 48:1-6, 1997.
107. Dumont Y, Fournier A, Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J Neurosci 18:5565-5574, 1998.
108. Migita K, Loewy AD, Ramabhadran TV, Krause JE, Waters SM. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res 889:23-37, 2001.
109. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, Hollenberg AN, Friedman JM, Elmquist JK. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 482:217-243, 2005.
110. Campbell RE, Ffrench-Mullen JM, Cowley MA, Smith MS, Grove KL. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology 74:106-119, 2001.
111. Allen JM, Fitzpatrick ML, Yeats JC, Darcy K, Adrian TE, Bloom SR. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30:255-262, 1984.
112. Yang H. Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 23:349-358, 2002.
113. Bonaz B, Taylor I, Tache Y. Peripheral peptide YY induces c-fos-like immunoreactivity in the rat brain. Neurosci Lett 163:77-80, 1993.
114. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654, 2002.
115. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88:3989-3992, 2003.
116. Halatchev IG, Ellacott KL, Fan W, Cone RD. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145:2585-2590, 2004.
117. Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thone-Reineke C, Benoit SC, Seeley RJ, Beck-sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castaneda TR, Tschop M. PYY3-36 as an anti-obesity drug target. Obes Rev 6:307-322, 2005.
118. Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, Heiman ML. Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 430:1, 2004.
119. Clark JT, Sahu A, Kalra PS, Balasubramaniam A, Kalra SP. Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([nor-Leu4]NPY) and peptide YY. Regul Pept 17:31-39, 1987.
120. Acuna-Goycolea C, van den Pol AN. Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci 25:10510-10519, 2005.
121. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124:1325-1336, 2003.
122. Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care 5:391-395, 2002.
123. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719, 2001.
124. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 19;407:908-913, 2000.
125. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328, 2000.
126. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992, 2001.
127. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547, 2001.
128. Petersenn S. Growth hormone secretagogues and ghrelin: an update on physiology and clinical relevance. Horm Res 58(Suppl 3):56-61, 2002.
129. Hewson AK, Dickson SL. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 12:1047-1049, 2000.
130. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141: 4797-4800, 2000.
131. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661, 2003.
132. van den TM, Lee K, Whyment AD, Blanks AM, Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci 7:493-494, 2004.
133. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703, 1996.
134. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289, 1996.
135. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749, 1995.
136. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26:439-451, 2005.
137. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953, 2001.
138. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881, 2001.
139. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.
140. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS. Adiponectin acts in the brain to decrease body weight. Nat Med 10:524-529, 2004.
141. Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschop M, Banks WA. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55:141-147, 2006.
142. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995.
143. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252, 1996.
144. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995.
145. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol 24:225-253, 2003.
146. Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab 16:307-313, 2005.
147. Mercer JG, Moar KM, Hoggard N. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology 139:29-34, 1998.
148. Shioda S, Funahashi H, Nakajo S, Yada T, Maruta O, Nakai Y. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci Lett 243:41-44, 1998.
149. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143:239-246, 2002.
150. Mercer JG, Moar KM, Findlay PA, Hoggard N, Adam CL. Association of leptin receptor (OB-Rb), NPY and GLP-1 gene expression in the ovine and murine brainstem. Regul Pept 75-76:271-278, 1998.
151. Emond M, Schwartz GJ, Ladenheim EE, Moran TH. Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol 276:R1545-R1549, 1999.
152. Ladenheim EE, Emond M, Moran TH. Leptin enhances feeding suppression and neural activation produced by systemically administered bombesin. Am J Physiol Regul Integr Comp Physiol 289: R473-R477, 2005.
153. Morton GJ, Blevins JE, Williams DL, Niswender KD, Gelling RW, Rhodes CJ, Baskin DG, Schwartz MW. Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest 115: 703-710, 2005.
154. Mayer J, Bates MW. Blood glucose and food intake in normal and hypophysectomized, alloxan-treated rats. Am J Physiol 168:812-819, 1952.
155. Stephens DB, Baldwin BA. The lack of effect of intrajugular or intraportal injections of glucose or amino-acids on food intake in pigs. Physiol Behav 12:923-929, 1974.
156. Bellinger LL, Trietley GJ, Bernardis LL. Failure of portal glucose and adrenaline infusions or liver denervation to affect food intake in dogs. Physiol Behav 16:299-304, 1976.
157. Strubbe JH, Steffens AB. Blood glucose levels in portal and peripheral circulation and their relation to food intake in the rat. Physiol Behav 19:303-307, 1977.
158. Thompson DA, Campbell RG. Hunger in humans induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. Science 198:1065-1068, 1977.
159. Smith GP, Epstein AN. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol 217:1083-1087, 1969.
160. Houpt TR, Hance HE. Stimulation of food intake in the rabbit and rat by inhibition of glucose metabolism with 2-deoxy-D-glucose. J Comp Physiol Psychol 76:395-400, 1971.
161. Kadekaro M, Timo-Iaria C, Valle LE. Neural systems responsible for the gastric secretion provoked by 2-deoxy-D-glucose cytoglucopoenia. J Physiol 252:565-584, 1975.
162. Rowland N, Watkins L, Carlton J. Failure of 2-deoxy-D-glucose to stimulate feeding in deermice. Physiol Behav 34:155-157, 1985.
163. Miselis RR, Epstein AN. Feeding induced by intracerebroventricular 2-deoxy-D-glucose in the rat. Am J Physiol 229:1438-1447, 1975.
164. Slusser PG, Ritter RC. Increased feeding and hyperglycemia elicited by intracerebroventricular 5-thioglucose. Brain Res 202:474-478, 1980.
165. Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213:451-452, 1981.
166. Ritter S, Taylor JS. Vagal sensory neurons are required for lipoprivic but not glucoprivic feeding in rats. Am J Physiol 258:R1395-R1401, 1990.
167. Ritter S, Dinh TT. 2-Mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreactivity in rat brain. Brain Res 641:111-120, 1994.
168. Contreras RJ, Fox E, Drubovich ML. Area postrema lesions produce feeding deficits in the rat: effects of preoperative dieting and 2-deoxy-D-glucose. Physiol Behav 29:875-884, 1982.
169. Edmonds BK, Edwards GL. Dorsomedial hindbrain participation in glucoprivic feeding response to 2DG but not 2DG-induced hyperglycemia or activation of the HPA axis. Brain Res 801:21-28, 1998.
170. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 51:2056-2065, 2002.
171. Adachi A, Kobashi M, Funahashi M. Glucose-responsive neurons in the brainstem. Obes Res 3(Suppl 5):735S-740S, 1995.
172. Funahashi M, Adachi A. Glucose-responsive neurons exist within the area postrema of the rat: in vitro study on the isolated slice preparation. Brain Res Bull 32:531-535, 1993.
173. Patil GD, Briski KP. Lactate is a critical "sensed" variable in caudal hindbrain monitoring of CNS metabolic stasis. Am J Physiol Regul Integr Comp Physiol 289:R1777-R1786, 2005.
174. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14:353-362, 1962.
175. Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, Lowell BB. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297:843-845, 2002.
176. Commins SP, Watson PM, Frampton IC, Gettys TW. Leptin selectively reduces white adipose tissue in mice via a UCP1-dependent mechanism in brown adipose tissue. Am J Physiol Endocrinol Metab 280:E372-E377, 2001.
177. Commins SP, Watson PM, Padgett MA, Dudley A, Argyropoulos G, Gettys TW. Induction of uncoupling protein expression in brown and white adipose tissue by leptin. Endocrinology 140:292-300, 1999.
178. Tsubone T, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept 130: 97-103, 2005.
179. Zorrilla EP, Inoue K, Fekete EM, Tabarin A, Valdez GR, Koob GF. Measuring meals: structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol 288:R1450-R1467, 2005.
180. Rossi R, Scharrer E. Circadian patterns of drinking and eating in pygmy goats. Physiol Behav 51:895-897, 1992.
181. Fitzsimons TJ, Le MJ. Eating as a regulatory control of drinking in the rat. J Comp Physiol Psychol 67:273-283, 1969.
182. Robinson EA, Adolf EF. Pattern of normal water drinking in dogs. Am J Physiol 139:39-44, 1943.
183. Ikemura R, Matsuwaki T, Yamanouchi K, Nishihara M. Involvement of endogenous vasopressin in high plasma osmolality-induced anorexia via V1 receptor-mediated mechanism. J Vet Med Sci 66: 951-955, 2004.
184. Edwards GL, Ritter RC. Ablation of the area postrema causes exaggerated consumption of preferred foods in the rat. Brain Res 216: 265-276, 1981.
185. Ritter RC, Edwards GL. Area postrema lesions cause overconsumption of palatable foods but not calories. Physiol Behav 32:923-927, 1984.
186. Edwards GL, Ritter RC. Area postrema lesions increase drinking to angiotensin and extracellular dehydration. Physiol Behav 29:943-947, 1982.